TY  - JOUR 
AU  - Martinón Torres, Federico
AU  - Mirás Carballal, Susana
AU  - Durán Parrondo, Carmen
PY  - 2023
SN  - 1560-7917
UR  - http://hdl.handle.net/20.500.11940/21377
AB  - A monoclonal antibody for universal respiratory syncytial virus prophylaxis in infants has recently been licensed. We share our experiences of integrating nirsevimab into the regional immunisation programme in Galicia, Spain. After a 3-week...
LA  - eng
KW  - Infant
KW  - Humans
KW  - Antibodies, Monoclonal
KW  - Palivizumab
KW  - Respiratory Syncytial Virus Infections
KW  - Spain
KW  - Respiratory Syncytial Viruses
KW  - Antiviral Agents
KW  - Respiratory Syncytial Virus, Human
TI  - Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023
DO  - 10.2807/1560-7917.es.2023.28.49.2300606
T2  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
KW  - AS Santiago
KW  - CHUS
KW  - DXSP
KW  - DXSP
VL  - 28
ER  -